PARP1 and myeloid sarcoma: Because NF‐κB is a master transcription factor for neuroinflammation in MS and EAE,[93] a growing number of studies have been dedicated to exploring the effect of inhibiting PARP1 activity on the disease course and pathology of MS patients and EAE animals.